{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:13:14Z","timestamp":1768925594373,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aed.2025.08.018","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:52:32Z","timestamp":1756947152000},"page":"2-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insulin Resistance Among Patients With Multiple Endocrine Neoplasia Type 1: A Systemic Review and Meta-Analysis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-8500","authenticated-orcid":false,"given":"Berk","family":"Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"De Mattei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Meireles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayed","family":"Shahatit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Kardouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.aed.2025.08.018_bib1","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.aed.2025.08.018_bib2","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/cells11152387","article-title":"Modeling MEN1 with patient-origin iPSCs reveals GLP-1R mediated hypersecretion of insulin","volume":"11","author":"Cheng","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.aed.2025.08.018_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR-gamma: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.aed.2025.08.018_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tem.2009.04.005","article-title":"Functional implications of genetic variation in human PPARgamma","volume":"20","author":"Jeninga","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.aed.2025.08.018_bib5","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/MCB.01001-08","article-title":"The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation","volume":"29","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.aed.2025.08.018_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.aed.2025.08.018_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-1-38","article-title":"Multiple endocrine neoplasia type 1","volume":"1","author":"Marini","year":"2006","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.aed.2025.08.018_bib8","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.aed.2025.08.018_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.aed.2025.08.018_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eprac.2025.02.001","article-title":"American association of clinical Endocrinology consensus statement on management of multiple endocrine neoplasia type 1","volume":"31","author":"Del Rivero","year":"2025","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.aed.2025.08.018_bib11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s002680010237","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death?","volume":"24","author":"Dean","year":"2000","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.aed.2025.08.018_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.aed.2025.08.018_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.aed.2025.08.018_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.2011.04166.x","article-title":"Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers","volume":"76","author":"van Wijk","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.aed.2025.08.018_bib15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.aed.2025.08.018_bib16","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1016\/j.ijcard.2006.05.033","article-title":"Primary hyperparathyroidism and the cardiovascular system","volume":"113","author":"Kiernan","year":"2006","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.aed.2025.08.018_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2265.2006.02563.x","article-title":"Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose","volume":"65","author":"McCallum","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.aed.2025.08.018_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejim.2005.09.008","article-title":"Patients with MEN-1 are more insulin-resistant than their non-affected relatives","volume":"16","author":"W\u00e4gner","year":"2005","journal-title":"Eur J Intern Med"},{"issue":"15","key":"10.1016\/j.aed.2025.08.018_bib19","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. MOOSE group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.aed.2025.08.018_bib20","series-title":"JBI Manual for Evidence Synthesis","article-title":"Chapter 7: systematic reviews of etiology and risk","author":"Moola","year":"2020"},{"key":"10.1016\/j.aed.2025.08.018_bib21","author":"Wells"},{"key":"10.1016\/j.aed.2025.08.018_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.aed.2025.08.018_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.aed.2025.08.018_bib24","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","year":"2024"},{"issue":"7650","key":"10.1016\/j.aed.2025.08.018_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.aed.2025.08.018_bib26","first-page":"753","article-title":"Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas","volume":"36","author":"Toaiari","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"Suppl 4","key":"10.1016\/j.aed.2025.08.018_bib27","first-page":"e634","article-title":"PD31-12: a comparison of inpatient admissions for pheochromocytoma in multiple endocrine neoplasia syndrome: a national inpatient sample analysis","volume":"203","author":"King","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.aed.2025.08.018_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cen.14252","article-title":"The clinical expression and impact of multiple endocrine neoplasia 1 during pregnancy","volume":"93","author":"Hogg","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.aed.2025.08.018_bib29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/MPA.0b013e318249d8f7","article-title":"Clinical burden of illness in patients with neuroendocrine tumors","volume":"41","author":"Hess","year":"2012","journal-title":"Pancreas"},{"issue":"Suppl 2","key":"10.1016\/j.aed.2025.08.018_bib30","doi-asserted-by":"crossref","first-page":"A421","DOI":"10.1210\/jendso\/bvac150.877","article-title":"RF05 | PSUN376: incidence of diabetes mellitus following pancreatic surgery in individuals with multiple endocrine neoplasia type 1","volume":"6","author":"Else","year":"2022","journal-title":"J Endocr Soc"},{"issue":"12","key":"10.1016\/j.aed.2025.08.018_bib31","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.3390\/ijms25126349","article-title":"Turning points in cross-disciplinary perspective of primary hyperparathyroidism and pancreas involvements: hypercalcemia-induced pancreatitis, MEN1 gene-related tumors, and insulin resistance","volume":"25","author":"Carsote","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6 Suppl","key":"10.1016\/j.aed.2025.08.018_bib32","article-title":"Abstract #1040290: the importance of detecting familial forms of primary hyperparathyroidism to determine management","volume":"27","author":"Bhargava","year":"2021","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.aed.2025.08.018_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF01654811","article-title":"The development of endocrinopathies in the prospective screening of two families with multiple endocrine adenopathy, type I","volume":"3","author":"Friesen","year":"1979","journal-title":"World J Surg"},{"issue":"Suppl 1","key":"10.1016\/j.aed.2025.08.018_bib34","article-title":"12406 Epidemiology of multiple endocrine neoplasia type 1 in South Korea: a nationwide cohort study","volume":"8","author":"Kim","year":"2024","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.aed.2025.08.018_bib35","article-title":"SUN-128 Impaired fasting glucose is associated with insulin resistance in patients with germline mutations in the multiple endocrine neoplasia type 1 (MEN1) gene","volume":"4","author":"Bansal","year":"2020","journal-title":"J Endocr Soc"},{"issue":"11","key":"10.1016\/j.aed.2025.08.018_bib36","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.2337\/dc14-0898","article-title":"Increased serum calcium levels and risk of type 2 diabetes in individuals at high cardiovascular risk","volume":"37","author":"Becerra-Tom\u00e1s","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.aed.2025.08.018_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI200522518","article-title":"CaV2.3 calcium channels control second-phase insulin release","volume":"115","author":"Jing","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.aed.2025.08.018_bib38","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2337\/diabetes.54.11.3336","article-title":"Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population","volume":"54","author":"Sun","year":"2005","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.aed.2025.08.018_bib39","doi-asserted-by":"crossref","first-page":"E1008","DOI":"10.1152\/ajpendo.00512.2001","article-title":"Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+)","volume":"282","author":"Ojuka","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.aed.2025.08.018_bib40","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/endo-125-5-2341","article-title":"Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes","volume":"125","author":"Draznin","year":"1989","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.aed.2025.08.018_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13578-023-01119-y","article-title":"Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPAR\u03b3","volume":"13","author":"Liu","year":"2023","journal-title":"Cell Biosci"},{"issue":"4","key":"10.1016\/j.aed.2025.08.018_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MPA.0000000000000509","article-title":"Progranulin stimulates proliferation of mouse pancreatic islet cells and is overexpressed in the endocrine pancreatic tissue of an MEN1 mouse model","volume":"45","author":"Barbu","year":"2016","journal-title":"Pancreas"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:29:24Z","timestamp":1768868964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S3050915725001080"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.08.018","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin Resistance Among Patients With Multiple Endocrine Neoplasia Type 1: A Systemic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Clinical Endocrinology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}